S S Burtles
- Biomaterials top 2%
- Polymers and Plastics top 10%
- Biomedical Engineering top 10%
-
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
-
- Cancer Treatment and Pharmacology 4
-
- Computational Drug Discovery Methods 3
-
- Diabetes and associated disorders 3
-
- Click Chemistry and Applications 2
-
- Pharmacogenetics and Drug Metabolism 2
S S Burtles
17 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Biomaterials 541
- Polymers and Plastics 99
- Biomedical Engineering 304
- Immunology 145
- Oncology 185
Countries citing papers authored by S S Burtles
This map shows the geographic impact of S S Burtles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S S Burtles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S S Burtles more than expected).
Fields of papers citing papers by S S Burtles
This network shows the impact of papers produced by S S Burtles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S S Burtles. The network helps show where S S Burtles may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S S Burtles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 7 | |
| 2 | 2004 | 16 | |
| 3 | 2003 | 3 | |
| 4 | 2003 | 12 | |
| 5 | 2002 | 12 | |
| 6 | 2002 | 214 | |
| 7 | 1999 | 43 | |
| 8 | Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.breakdown → | 1999 | 574 |
| 9 | 1998 | 59 | |
| 10 | 1994 | 37 | |
| 11 | 1993 | 14 | |
| 12 | 1992 | 16 | |
| 13 | 1992 | 1 | |
| 14 | Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms. | 1992 | 69 |
| 15 | The effect of neonatal tolerance to bovine gamma globulin (BGG) on BGG-reactive CD4+ T lymphocytes. | 1992 | 4 |
| 16 | 1990 | 10 | |
| 17 | 1984 | 11 |
About S S Burtles
S S Burtles is a scholar working on Immunology, Statistics and Probability, Pharmacology, Computational Theory and Mathematics and Biomaterials, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), T-cell and B-cell Immunology (4 papers), Computational Drug Discovery Methods (3 papers), Diabetes and associated disorders (3 papers), Immunotherapy and Immune Responses (3 papers), Click Chemistry and Applications (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Biomaterials (541 citations), Polymers and Plastics (99 citations), Biomedical Engineering (304 citations), Immunology (145 citations) and Oncology (185 citations). S S Burtles has collaborated with scholars based in United Kingdom, Netherlands and Belgium. Frequent co-authors include Ruth Duncan, Peter D. Wilson, Lilian S. Murray, P. Vasey, T. E. Hilditch, J Cassidy, T. Murray, Rachel Morrison, Alison H. Thomson and E. Frigerio. Their work appears in journals such as British Journal of Cancer, The Journal of Immunology, Neurochemical Research, Journal of Clinical Oncology and Journal of Autoimmunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.